Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis
Cells · 06.02.2023 · 12 (4) · 525
DOI: 10.3390/cells12040525 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 06.02.2023. Verfasst von Euclides Jordan-Alejandre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de México 03100, Mexico. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología (CONACYT).
Abstract (Originalsprache)
Breast cancer is the most common cancer in women. Despite advances in diagnosis and prognosis, distal metastases occur in these patients in up to 15% of cases within 3 years of diagnosis. The main organs in which BC metastasises are the bones, lungs, liver, and brain. Unfortunately, 90% of metastatic patients will die, making this an incurable disease. Researchers are therefore seeking biomarkers for diagnosis and metastasis in different organs. Optimally, such biomarkers should be easy to detect using, preferably, non-invasive methods, such as using miRNA molecules, which are small molecules of about 22 nt that have as their main function the post-transcriptional regulation of genes. Furthermore, due to their uncomplicated detection and reproducibility in the laboratory, they are a tool of complementary interest for diagnosis, prognosis, and treatment. With this in mind, in this review, we focus on describing the most current studies that propose using miRNA independently as a potential biomarker for the diagnosis and prediction of brain, lung, liver, and bone metastases, as well as to open a window of opportunity to deepen this area of study to eventually use miRNAs molecules in clinical practice for the benefit of BC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de México 03100, Mexico.
- Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Ciudad de México 14080, Mexico.
- Facultad de Ingeniería, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.
- Coordinación Académica Región Altiplano, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78760, Mexico.
ORCID-Profile: Euclides Jordan-Alejandre, Alma D Campos-Parra, Macrina Beatriz Silva-Cázares
Förderung
- Consejo Nacional de Ciencia y Tecnología (CONACYT)
Zitieren
APA
Jordan-Alejandre, E., Campos-Parra, A. D., Castro-López, D. L., & Silva-Cázares, M. B. (2023). Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis. Cells, 12(4), 525. https://doi.org/10.3390/cells12040525
Vancouver
Jordan-Alejandre E, Campos-Parra AD, Castro-López DL, Silva-Cázares MB. Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis. Cells. 2023;12(4):525. doi:10.3390/cells12040525
BibTeX
@article{JordanAlejandre2023,
author = {Jordan-Alejandre, Euclides and Campos-Parra, Alma D and Castro-López, Dora Luz and Silva-Cázares, Macrina Beatriz},
title = {Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis},
journal = {Cells},
year = {2023},
volume = {12},
number = {4},
pages = {525},
doi = {10.3390/cells12040525}
}
EUVIMED